The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials
Open accessAbstract
Background—: Thrombolytic therapy with intravenous alteplase within 4.5 hours of ischemic stroke onset increases the overall likelihood of an excellent outcome (no, or nondisabling, symptoms). Any improvement in functional outcome distribution has value, and herein we provide an assessment of the effect of alteplase on the distribution of the functional level by treatment delay, age, and stroke severity. Methods—: Prespecified pooled analysis of 6756 patients from 9 randomized trials comparing alteplase versus placebo/open control. Ordinal logistic regression models assessed treatment differences after adjustment for treatment delay, age, stroke severity, and relevant interaction term(s). Results—: Treatment with alteplase was beneficial for a delay in treatment extending to 4.5 hours after stroke onset, with a greater benefit with earlier treatment. Neither age nor stroke severity significantly influenced the slope of the relationship between benefit and time to treatment initiation. For the observed case mix of patients treated within 4.5 hours of stroke onset (mean 3 hours and 20 minutes), the net absolute benefit from alteplase (ie, the difference between those who would do better if given alteplase and those who would do worse) was 55 patients per 1000 treated (95% confidence interval, 13–91; P =0.004). Conclusions—: Treatment with intravenous alteplase initiated within 4.5 hours of stroke onset increases the chance of achieving an improved level of function for all patients across the age spectrum, including the over 80s and across all severities of stroke studied (top versus bottom fifth means: 22 versus 4); the earlier that treatment is initiated, the greater the benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684
Self-citationRegression Models for Ordinal Data
McCullagh, P. (1980) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1980.tb01109.x · Cited by 4,453
Hacke, W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D., Larrue, V., Bluhmki, E., Davis, S., Donnan, G., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)08020-9 · Cited by 3,662
Self-citationEmberson, J., Lees, K. R., Lyden, P., Blackwell, L., Albers, G., Bluhmki, E., Brott, T., Cohen, G., Davis, S., Donnan, G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60584-5 · Cited by 2,737
Self-citationBenardete, E. A., & Nair, A. K. (2015) · Cerebrovascular Diseases Extra · doi:10.1159/000370060 · Cited by 2,546
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Hacke, W. (1995) · JAMA · doi:10.1001/jama.1995.03530130023023 · Cited by 2,403
Self-citationLees, K. R., Bluhmki, E., von Kummer, R., Brott, T. G., Toni, D., Grotta, J. C., Albers, G. W., Kaste, M., Marler, J. R., Hamilton, S. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60491-6 · Cited by 2,184
Self-citationAoki, J., Kimura, K., Shibazaki, K., & Sakamoto, Y. (2013) · Cerebrovascular Diseases Extra · doi:10.1159/000348552 · Cited by 1,929
Clark, W. M., Wissman, S., Albers, G. W., Jhamandas, J. H., Madden, K. P., Hamilton, S., & for the ATLANTIS Study Investigators (1999) · JAMA · doi:10.1001/jama.282.21.2019 · Cited by 1,186
Self-citationDavis, S. M., Donnan, G. A., Parsons, M. W., Levi, C., Butcher, K. S., Peeters, A., Barber, P. A., Bladin, C., De Silva, D. A., Byrnes, G., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70044-9 · Cited by 1,052
Self-citationThe Effect of Stroke and Stroke Prophylaxis With Aspirin or Warfarin on Quality of Life
Gage, B. F. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.16.1829 · Cited by 370
Statistical Analysis of the Primary Outcome in Acute Stroke Trials
Bath, P. M. W., Lees, K. R., Schellinger, P. D., Altman, H., Bland, M., Hogg, C., Howard, G., & Saver, J. L. (2012) · Stroke · doi:10.1161/strokeaha.111.641456 · Cited by 266
Self-citationContemporary Outcome Measures in Acute Stroke Research: Choice of Primary Outcome Measure
Lees, K. R., Bath, P. M. W., Schellinger, P. D., Kerr, D. M., Fulton, R., Hacke, W., Matchar, D., Sehra, R., & Toni, D. (2012) · Stroke · doi:10.1161/strokeaha.111.641423 · Cited by 242
Self-citationWhiteley, W. N., Emberson, J., Lees, K. R., Blackwell, L., Albers, G., Bluhmki, E., Brott, T., Cohen, G., Davis, S., Donnan, G., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30076-x · Cited by 239
Self-citationHong, K.-S., & Saver, J. L. (2009) · Stroke · doi:10.1161/strokeaha.109.561365 · Cited by 213
Howard, G., Waller, J. L., Voeks, J. H., Howard, V. J., Jauch, E. C., Lees, K. R., Nichols, F. T., Rahlfs, V. W., & Hess, D. C. (2012) · Stroke · doi:10.1161/strokeaha.111.632935 · Cited by 82
Self-citationDawson, J., Lees, J. S., Chang, T.-P., Walters, M. R., Ali, M., Davis, S. M., Diener, H., & Lees, K. R. (2007) · Stroke · doi:10.1161/strokeaha.106.472381 · Cited by 72
Self-citationEffect Size Measures and Their Relationships in Stroke Studies
Rahlfs, V. W., Zimmermann, H., & Lees, K. R. (2013) · Stroke · doi:10.1161/strokeaha.113.003151 · Cited by 30
Self-citationThe Stroke Thrombolysis Trialists' Collaborative Group (2013) · International Journal of Stroke · doi:10.1111/ijs.12040 · Cited by 24
Cited by
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2018) · Stroke · doi:10.1161/str.0000000000000158 · Cited by 5,446
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Berge, E., Whiteley, W., Audebert, H., De Marchis, G., Fonseca, A. C., Padiglioni, C., Pérez de la Ossa, N., Strbian, D., Tsivgoulis, G., & Turc, G. (2021) · European Stroke Journal · doi:10.1177/2396987321989865 · Cited by 1,355
Self-citationMRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
Thomalla, G., Simonsen, C. Z., Boutitie, F., Andersen, G., Berthezene, Y., Cheng, B., Cheripelli, B., Cho, T.-H., Fazekas, F., Fiehler, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804355 · Cited by 1,327
Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review
Mendelson, S. J., & Prabhakaran, S. (2021) · JAMA · doi:10.1001/jama.2020.26867 · Cited by 784
Metadata
- Authors
- Lees, K. R., Emberson, J., Blackwell, L., Bluhmki, E., Davis, S. M., Donnan, G. A., Grotta, J. C., Kaste, M., von Kummer, R., Lansberg, M. G., Lindley, R. I., Lyden, P., Murray, G. D., Sandercock, P. A. G., Toni, D., Toyoda, K., Wardlaw, J. M., Whiteley, W. N., Baigent, C., Hacke, W., Howard, G., Marler, J., Halls, H., Holland, L., Mathews, C., Smith, S., Wilson, K., Koga, M., Albers, G., Brott, T., Cohen, G., Koga, M., Olivot, J. M., Parsons, M., Tilley, B., Wahlgren, N., & del Zoppo, G. J.
- Venue
- Stroke
- Published
- 2016-09
- Volume
- 47
- Issue
- 9
- Pages
- 2373-2379
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2516637150
- Cited by
- 256
- References
- 23
- FWCI
- 18.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.